WINDLAS BIOTECH Share price

The Company was incorporated as ‘Windlas Biotech Limited’ on February 19 2001 at New Delhi as a public limited company under the Companies Act 1956 and was granted a certificate of incorporation by RoC Delhi. Further the Company received the certificate for commencement of business on March 5 2001 from the RoC Delhi. The Registered Office of the Company was shifted from the state of Delhi to the state of Uttarakhand pursuant to a special resolution passed by the Shareholders on August 22 2009. The alteration with respect to the place of the Registered Office was confirmed by the order of the Company Law Board New Delhi on August 5 2010 and a fresh certificate of registration was issued by the Registrar of Companies Uttar Pradesh and Uttarakhand located at Kanpur on February 18 2011. Subsequently the Company was converted into a private limited company pursuant to a special resolution passed by the Shareholders on March 30 2016 and a fresh certificate of incorporation consequent upon conversion and change of name to ‘Windlas Biotech Private Limited’ was granted by the Registrar of Companies Uttarakhand located at Kanpur on July 22 2016. the Company was converted from a private limited company to a public limited company pursuant to a special resolution passed by the Shareholders on April 3 2021 and the name of the Company was changed to ‘Windlas Biotech Limited’. A fresh certificate of incorporation dated April 15 2021 consequent upon change of name on conversion to a public limited company was granted by the RoC.Major events and milestones of the Company :2021- Approval of Scheme of Amalgamation of the erstwhile subsidiary Windlas Healthcare with and into the Company2018- Launched first product in the United States from the Dehradun Plant – IV situated at plot no. 183 and 192 Mohabewala Industrial Area Dehradun 248 110- Commenced operations at Dehradun Plant – III situated at plot no. 39 Pharmacity Selaqui Dehradun 248 1972017- Revenues crossed Rs. 3000 million for the FY 2016-172015- Investment of Rs. 750 million from Tano India Private Equity Fund II2014- Received first USFDA inspection clearance for the WHC Plant- Revenues crossed Rs. 2000 million for the FY 2013-14- Commenced operations at Dehradun Plant – II situated at khasra no. 141 to 143 and 145 Mohabewala Industrial Area Dehradun 248 1102010- Revenues crossed Rs. 1000 million for the FY 2009-102009- Commenced operations at Dehradun Plant – IV situated at plot no. 183 and 192 Mohabewala Industrial Area Dehradun 248 1102001- Commenced operations at Dehradun Plant – I situated at 40/1 Mohabewala Industrial Area Dehradun 248 110 and initiated commercial productionAwards accreditations and recognitions received by the Company :2019- The Company was awarded the certificate of appreciation from the Secretary Bureau of Energy Efficiency for valuable contributions in implementing energy efficiency and cleaner production measures under the project ‘Financing Energy Efficiency at MSMEs’.- The Company was awarded the certificate of partnership recognising the contribution to and participation in the Swasth Bharat Yatra a pan-India cyclothon organised by the Food Safety and Standards Authority of India.2018- The Company was awarded the TV100 Industrial Excellence Award in the field of medicine.